Table 4 Dosage duration, defined daily dose, and cost distributed across appropriate or inappropriate indication
Characteristic | Overall, N = 991 | Appropriate indication N = 571 | Inappropriate indication, N = 421 | p-value2 |
|---|---|---|---|---|
Dosage duration by days median (IQR) | 7.0 (4.0, 11.0) | 7.0 (4.0, 11.0) | 6.0 (4.2, 10.8) | 0.8 |
Defined daily dose( DDD median (IQR) | 7.0 (4.0, 11.0) | 7.0 (4.0, 11.0) | 6.0 (4.2, 10.8) | 0.8 |
Total DDD | 765 | 445 | 320 | |
Cost median (IQR) | 655 (374, 1,030) | 655 (374, 1,030) | 562 (398, 1,006) | 0.8 |
Total cost | 71,535.3LE | 41,583.8 LE (58.1%) | 29,951.5 LE (41.9%) |